| [1] |
Abrams P, Cardozo L, Fall M, et al. The standardisation of terminology of lower urinary tract function: report from the standardisation sub-committee of the international continence society[J]. Neurourol Urodyn, 2002, 21(2): 167-178.
|
| [2] |
Gratzke C, Bachmann A, Descazeaud A, et al. EAU guidelines on the assessment of non-neurogenic male lower urinary tract symptoms including benign prostatic obstruction[J]. Eur Urol, 2015, 67(6): 1099-1109.
|
| [3] |
陈忠, 叶章群. 良性前列腺增生手术时机的探讨[J] 中华泌尿外科杂志[J]. 2021, 42(12): 881-884.
|
| [4] |
Aho T, Finch W, Jefferson P, et al. HoLEP for acute and non-neurogenic chronic urinary retention: how effective is it?[J]. World J Urol, 2021, 39(7): 2355-2361.
|
| [5] |
Law YXT, Castellani D, Dell'atti L, et al. Differences in surgical and functional outcomes in benign prostate hyperplasia patients with only lower urinary tract symptoms versus those in retention: a systematic review and meta-analysis[J]. Neurourol Urodyn, 2021, 40(6): 1389-1401.
|
| [6] |
Teoh J, Chan C-K, Wang M, et al. Transurethral resection of prostate for acute urinary retention is linked to shorter survival in younger men[J]. 2019, 21(5): 468-472.
|
| [7] |
Thiruchelvam N, Drake MJ, Venn S, et al. A 2014 snapshot audit of the role of urodynamics in the UK for benign prostatic enlargement surgery[J]. Neurourol Urodyn, 2016, 35(2): 271-272.
|
| [8] |
Luciani LG, Mattevi D, Ravanelli D, et al. A novel nomogram based on initial features to predict BPH progression[J]. Int J Environ Res Public Health, 2022, 19(15): 9738..
|
| [9] |
Liu HH, Tsai TH, Lee SS, et al. Maximum urine flow rate of less than 15ml/sec increasing risk of urine retention and prostate surgery among patients with alpha-1 blockers: a 10-year follow up study[J]. PLoS One, 2016, 11(8): e0160689.
|
| [10] |
Kim M, Jeong CW, Oh SJ. Diagnostic value of urodynamic bladder outlet obstruction to select patients for transurethral surgery of the prostate: Systematic review and meta-analysis[J]. PLoS One, 2017, 12(2): e0172590.
|
| [11] |
Jeong J, Lee HS, Cho WJ, et al. Effect of detrusor overactivity on functional outcomes after holmium laser enucleation of the prostate in patients with benign prostatic obstruction[J]. Urology, 2015, 86(1): 133-138.
|
| [12] |
Zhao YR, Liu WZ, Guralnick M, et al.Predictors of short-term overactive bladder symptom improvement after transurethral resection of prostate in men with benign prostatic obstruction[J]. Int J Urol, 2014, 21(10): 1035-1040.
|
| [13] |
Yao W, Wu F, Zhang D, et al. Impacts of preoperative maximum detrusor pressure on minimally invasive surgery effect on patients with benign prostatic hyperplasia[J]. Minerva Chir, 2020, 75(1): 25-29.
|
| [14] |
Zhong P, Zhao YR, Qiao BM, et al. Comparison of two numerical parameters to assess detrusor contractility in prognosing short-term outcome after transurethral resection of the prostate[J]. Urol Int, 2020, 104(5-6): 361-366.
|
| [15] |
Cao N, Lu Q, Si J, et al. The characteristics of the transitional zone in prostate growth with age[J]. Urology, 2017, 105: 136-140.
|
| [16] |
刘洪明, 田野, 苏志勇, 等. 前列腺总体积及移行带体积对良性前列腺增生症经尿道前列腺电切术疗效的影响[J]. 中华医学杂志, 2021, 101(2): 137-141.
|
| [17] |
苏志勇, 刘洪明, 田野, 等. 移行带指数对经尿道前列腺电切术疗效的影响分析[J].中华医学杂志, 2020(6): 452-453-454-455.
|
| [18] |
Yoshida T, Kinoshita H, Yoshida K, et al. Intravesical prostatic protrusion as a predicting factor for the adverse clinical outcome in patients with symptomatic benign prostatic enlargement treated with dutasteride[J]. Urology, 2016, 91: 154-157.
|
| [19] |
Eze BU, Ani CO, Mbaeri TU. Is intravesical prostatic protrusion associated with more complications in benign prostatic hyperplasia patients?[J]. Low Urin Tract Symptoms, 2021, 13(4): 468-474.
|
| [20] |
Hirayama K, Masui K, Hamada A, et al. Evaluation of intravesical prostatic protrusion as a predictor of dutasteride-resistant lower urinary tract symptoms/benign prostatic enlargement with a high likelihood of surgical intervention[J]. Urology, 2015, 86(3): 565-569.
|
| [21] |
Radwan M, Rashed A, Zaghloul T, et al. Evaluation of ultrasonographic predictors of alpha-blocker mono-therapy failure in symptomatic benign prostatic enlargement[J]. Urol Ann, 2021, 13(3): 220-225.
|
| [22] |
Bang WJ, Kim HW, Lee JY, et al. Prostatic urethral angulation associated with urinary flow rate and urinary symptom scores in men with lower urinary tract symptoms[J]. Urology, 2012, 80(6): 1333-1337.
|
| [23] |
Shim M, Bang WJ, Oh CY, et al. Correlation between prostatic urethral angulation and symptomatic improvement after surgery in patients with lower urinary tract symptoms according to prostate size[J]. World J Urol, 2020, 38(8): 1997-2003.
|
| [24] |
Kang DH, Lee JY, Hah YS, et al. Correlation of prostatic urethral angle with the severity of urinary symptom and peak flow rate in men with small prostate volume[J]. PLoS One, 2014, 9(8): e104395.
|
| [25] |
Li XD, Wu YP, Ke ZB, et al. Predictors of postoperative lower urinary tract symptoms improvements in patient with small-volume prostate and bladder outlet obstruction[J]. Ther Clin Risk Manag, 2019, 15: 1291-1304.
|
| [26] |
Hou CP, Chen CL, Lin YH, et al. Prostatic urethral angle might be a predictor of treatment efficacy of α-blockers in men with lower urinary tract symptoms[J]. Drug Des Devel Ther, 2014, 8: 937-943.
|
| [27] |
Ko YH, Kim TH, Song PH, et al. Structural variations of the prostatic urethra within the prostate predict the severities of obstructive symptoms: a prospective multicenter observational study[J]. Urology, 2017, 104: 160-165.
|
| [28] |
Oka S, Kobayashi K, Matsuda K, et al. Significance of membranous urethral length for recovery from postoperative urinary incontinence following holmium laser enucleation of the prostate[J]. Int Neurourol J, 2020, 24(4): 358-364.
|
| [29] |
Ueki H, Takahashi K, Yasufuku T, et al. Is the membranous urethral length related to postoperative urinary incontinence after holmium laser enucleation of the prostate?[J]. Int J Urol, 2020, 27(10): 893-898.
|
| [30] |
Kim BS, Ko YH, Song PH, et al. Prostatic urethral length as a predictive factor for surgical treatment of benign prostatic hyperplasia: a prospective, multiinstitutional study[J]. Prostate Int, 2019, 7(1): 30-34.
|
| [31] |
Tsuru N, Kurita Y, Suzuki K, et al. Resistance index in benign prostatic hyperplasia using power doppler imaging and clinical outcomes after transurethral vaporization of the prostate[J]. Int J Urol, 2005, 12(3): 264-269.
|
| [32] |
Suzuki T, Otsuka A, Ozono S. Combination of intravesical prostatic protrusion and resistive index is useful to predict bladder outlet obstruction in patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia[J]. Int J Urol, 2016, 23(11): 929-933.
|
| [33] |
Garg G, Sankhwar SN, Goel A, et al. Evaluation of resistive index of the prostate and bladder sonomorphologic parameters as replacements for urodynamics to predict bladder outlet obstruction in patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia[J]. Low Urin Tract Symptoms, 2019, 11(3): 163-168.
|
| [34] |
Huang T, Qi J, Yu YJ, et al. Predictive value of resistive index, detrusor wall thickness and ultrasound estimated bladder weight regarding the outcome after transurethral prostatectomy for patients with lower urinary tract symptoms suggestive of benign prostatic obstruction[J]. Int J Urol, 2012, 19(4): 343-350.
|
| [35] |
Shinbo H, Kurita Y, Nakanishi T, et al. Resistive index: a newly identified predictor of outcome of transurethral prostatectomy in patients with benign prostatic hyperplasia[J]. Urology, 2010, 75(1): 143-147.
|
| [36] |
Schäfer W. Analysis of bladder-outlet function with the linearized passive urethral resistance relation, linPURR, and a disease-specific approach for grading obstruction: from complex to simple[J]. World J Urol, 1995, 13(1): 47-58.
|
| [37] |
Rademakers KL, Van Koeveringe GA, Oelke M. Detrusor underactivity in men with lower urinary tract symptoms/benign prostatic obstruction: characterization and potential impact on indications for surgical treatment of the prostate[J]. Curr Opin Urol, 2016, 26(1): 3-10.
|
| [38] |
Cho MC, Yoo S, Park J, et al. Effect of preoperative detrusor underactivity on long-term surgical outcomes of photovaporization and holmium laser enucleation in men with benign prostatic hyperplasia: a lesson from 5-year serial follow-up data[J]. BJU Int, 2019, 123(5a): E34-e42.
|
| [39] |
Abdelhakim MA, Rammah A, Abozamel AH, et al. Does detrusor underactivity affect the results of transurethral resection of prostate?[J]. Int Urol Nephrol, 2021, 53(2): 199-204.
|
| [40] |
Rubilotta E, Balzarro M, Gubbiotti M, et al. Outcomes of transurethral resection of the prostate in unobstructed patients with concomitant detrusor underactivity[J]. Neurourol Urodyn, 2020, 39(8): 2179-2185.
|
| [41] |
Sharifiaghdas F, Khoiniha MR, Basiri A, et al. Benign prostatic hyperplasia: who will benefit from surgical intervention? A single center experience[J]. Urologia, 2022, 89(3): 371-377..
|
| [42] |
Zhu Y, Zhao YR, Zhong P, et al. Detrusor underactivity influences the efficacy of TURP in patients with BPO[J]. Int Urol Nephrol, 2021, 53(5): 835-841.
|
| [43] |
De Nunzio C, Brassetti A, Proietti F, et al. Dutasteride add-on therapy reduces detrusor mass in patients with benign prostatic enlargement not satisfied with alpha-adrenergic antagonist monotherapy: A single center prospective study[J]. Neurourol Urodyn, 2017, 36(8): 2096-2100.
|
| [44] |
Park J, Suh J, Yoo S, et al. Bladder wall thickness and detrusor wall thickness can help to predict the bladder outlet obstruction in men over the age of 70 years with symptomatic benign prostatic hyperplasia[J]. Investig Clin Urol, 2020, 61(5): 491-497.
|
| [45] |
Salah Azab S, Elsheikh MG. The impact of the bladder wall thickness on the outcome of the medical treatment using alpha-blocker of BPH patients with LUTS[J]. Aging Male, 2015, 18(2): 89-92.
|
| [46] |
Kojima Y, Sasaki S, Kubota Y, et al. Expression of alpha1-adrenoceptor subtype mRNA as a predictor of the efficacy of subtype selective alpha1-adrenoceptor antagonists in the management of benign prostatic hyperplasia[J]. J Urol, 2008, 179(3): 1040-1046.
|
| [47] |
Niu Y, Ge R, Hu L, et al. Reduced levels of 5-α reductase 2 in adult prostate tissue and implications for BPH therapy[J]. Prostate, 2011, 71(12): 1317-1324.
|
| [48] |
Kang PM, Kim YJ, Seo WT, et al. Correlation between 5-α reductase type 2 protein expression and methylation of 5-α reductase type 2 promotor gene of benign prostatic hyperplasia[J]. World J Urol, 2019, 37(4): 709-718.
|
| [49] |
Bechis SK, Otsetov AG, Ge R, et al. Age and obesity promote methylation and suppression of 5α-reductase 2: implications for personalized therapy of benign prostatic hyperplasia[J]. J Urol, 2015, 194(4): 1031-1037.
|